Navigation Links
Advantage India: Growth Pills Abound For Pharma Companies

It's advantage Indian pharma companies and the needy patients who would have to fork out much less to purchase life-saving drugs, with global pharma giants like Merck and Pfizer losing// their patent on drugs commanding multi-billion annual sales.

Domestic pharma majors Ranbaxy and Dr Reddy's Laboratories are being touted as major beneficiaries to tap on a multi-billion dollar sales vacuum created by the patent expiry of two biggest blockbuster drugs in the US -- cholesterol- cutting drug Zocor and antidepressant Zoloft -- within the span of a week.

Merck's patent for Zocor that contributed USD 4.4 billion in the company's 2005 sales expired on June 23, while Pfizer loses its patent for Zoloft, which totalled USD 3.3 billion in 2005 sales, on June 30.

When a company loses its exclusive patent for a branded drug, market opens to a host of generic drugmakers that leads to a drop of nearly 80 per cent in the drug's price, which results in a major gain for consumers as well as the makers of generic version of these drugs.

While analysts expect good value addition in share prices of DRL and Ranbaxy on the back of patent related global news flow going forward, another pharma major Cipla has already outperformed the Sensex since June 14, when the 30-share barometer index had plummeted to its lowest level in past few months at 8,799.01.

Cipla has gained 17.91 per cent since June 14 as against a gain of 16.48 per cent in Sensex. Ranbaxy on the other hand rose 11.01 per cent and DRL 8.51 per cent during the same period.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Advantages of Red Wine
2. Inactivation of Rad9 in Tumor Cells Would Be Advantageous In Cancer Therapy
3. Competitive Advantage Are Attained In Which Freeloaders Are Punished
4. Retro Running Is Found To Be More Advantageous
5. New Antipsychotic Medications have Little Advantage Over Older Drugs
6. "New" Clear Advantages In Nuclear Medicine
7. HIV Takes Advantage of Rivalry among T cells
8. Advantage Coffee and Disadvantage-Diabetes
9. Obesity - An Advantage For MHD Patients
10. Advantage, Obese Men!!
11. Vitamin A supplementation inadequate in India: Need for effective strategies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will ... of Music Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention ... long been the gold standard for high-definition, in-ear earphones. This classic earphone has ...
(Date:1/17/2017)... ... 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting provider ... in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted that ... , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug Administration ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons ... to primary eye care practitioners on the latest breakthroughs in the prevention, diagnosis ... Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive ...
(Date:1/17/2017)... ... 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New Jersey ... region, is launching a charity drive to raise awareness of heart disease and promote ... in America, and is responsible for 1 in every 4 deaths at the national ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Research Future published a Half Cooked Research Report on Endoscopy Devices ... 33.6 million during the period 2016 to 2022 from USD 28.7 ... ... examined as a swiftly growing market and expected to grow at ... in various regions.  The increasing growth in endoscopy procedures is influencing ...
(Date:1/17/2017)... KANSAS CITY, Mo. , Jan. ... (CHNC) has selected Velos and its flagship technology ... and multicenter initiatives. CHNC is a ... Neonatal Intensive Care Units at leading children,s hospitals ... consortium provides a benchmark of care and short-term ...
(Date:1/17/2017)...  Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is ... Inc. ("Anthera" or the "Company") (NASDAQ: ANTH ). ... the investigation by visiting the firm,s site: www.bgandg.com/anth .   ... its officers and/or directors have violated Sections 10(b) and 20(a) ... ...
Breaking Medicine Technology: